Intraventricular quinupristin/dalfopristin for the treatment of vancomycin-resistant Enterococcus faecium shunt infection.
Tush
G M
GM
Department of Pharmacy, Virginia Commonwealth University, Medical College of Virginia Hospitals, Richmond, USA.
Huneycutt
S
S
Phillips
A
A
Ward
J D
JD
D000328:Adult; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination; D016984:Enterococcus faecium; D016908:Gram-Positive Bacterial Infections / Q000188:drug therapy*; D006801:Humans; D007276:Injections, Intraventricular; D008297:Male; D014640:Vancomycin / Q000627:therapeutic use*; D017287:Ventriculoperitoneal Shunt / Q000009:adverse effects*; D014769:Virginiamycin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D014769:Virginiamycin; C113825:quinupristin; D014640:Vancomycin; C113826:dalfopristin